He Y - Search Results

1

Necroptosis inhibitors: mechanisms of action and therapeutic potential.

Zhou Y, Cai Z, Zhai Y, Yu J, He Q, He Y, Jitkaew S, Cai Z. Zhou Y, et al. Among authors: he y, he q. Apoptosis. 2024 Feb;29(1-2):22-44. doi: 10.1007/s10495-023-01905-6. Epub 2023 Nov 24. Apoptosis. 2024. PMID: 38001341 Review.

2

Targeting Necroptosis as a Promising Therapy for Alzheimer's Disease.

Zhao W, Liu Y, Xu L, He Y, Cai Z, Yu J, Zhang W, Xing C, Zhuang C, Qu Z. Zhao W, et al. Among authors: he y. ACS Chem Neurosci. 2022 Jun 15;13(12):1697-1713. doi: 10.1021/acschemneuro.2c00172. Epub 2022 May 23. ACS Chem Neurosci. 2022. PMID: 35607807 Review.

3

The regulation of necroptosis by ubiquitylation.

Chen Y, Ren W, Wang Q, He Y, Ma D, Cai Z. Chen Y, et al. Among authors: he y. Apoptosis. 2022 Oct;27(9-10):668-684. doi: 10.1007/s10495-022-01755-8. Epub 2022 Aug 8. Apoptosis. 2022. PMID: 35939135 Review.

4

Identification of a marine-derived sesquiterpenoid, Compound-8, that inhibits tumour necrosis factor-induced cell death by blocking complex II assembly.

He Y, Yang T, Li J, Li K, Zhuang C, Zhang M, Li R, Zhao Y, Song Q, Jiang M, Mao S, Song XG, Guo Y, Li X, Tan F, Jitkaew S, Zhang W, Cai Z. He Y, et al. Br J Pharmacol. 2024 Mar 31. doi: 10.1111/bph.16364. Online ahead of print. Br J Pharmacol. 2024. PMID: 38555910

5

Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy.

Zhu J, Xin M, Xu C, He Y, Zhang W, Wang Z, Zhuang C. Zhu J, et al. Among authors: he y. Acta Pharm Sin B. 2021 Oct;11(10):3193-3205. doi: 10.1016/j.apsb.2021.05.017. Epub 2021 May 24. Acta Pharm Sin B. 2021. PMID: 34729309 Free PMC article.

6

Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis.

Wang F, Wang JN, He XY, Suo XG, Li C, Ni WJ, Cai YT, He Y, Fang XY, Dong YH, Xing T, Yang YR, Zhang F, Zhong X, Zang HM, Liu MM, Li J, Meng XM, Jin J. Wang F, et al. Among authors: he xy, he y. Acta Pharmacol Sin. 2022 Feb;43(2):330-341. doi: 10.1038/s41401-021-00649-w. Epub 2021 Apr 8. Acta Pharmacol Sin. 2022. PMID: 33833407 Free PMC article.

7

Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.

He XY, Wang F, Suo XG, Gu MZ, Wang JN, Xu CH, Dong YH, He Y, Zhang Y, Ji ML, Chen Y, Zhang MM, Fan YG, Wen JG, Jin J, Wang J, Li J, Zhuang CL, Liu MM, Meng XM. He XY, et al. Among authors: he y. Br J Pharmacol. 2023 Oct;180(20):2641-2660. doi: 10.1111/bph.16152. Epub 2023 Jul 1. Br J Pharmacol. 2023. PMID: 37248964

8

Discovery of a chalcone derivative as potent necroptosis inhibitor for the treatment of acute kidney injury.

Li C, Chen QY, He Y, Liu YH, Meng XM, Liu MM. Li C, et al. Among authors: he y. Clin Exp Pharmacol Physiol. 2022 Aug;49(8):824-835. doi: 10.1111/1440-1681.13670. Epub 2022 Jun 23. Clin Exp Pharmacol Physiol. 2022. PMID: 35579574

9

RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.

Xu CH, Wang JN, Suo XG, Ji ML, He XY, Chen X, Zhu S, He Y, Xie SS, Li C, Dong ZH, Chen Y, Ni WJ, Feng XW, Liu MM, Jin J, Li Z, Meng XM. Xu CH, et al. Among authors: he xy, he y. Int Immunopharmacol. 2022 Nov;112:109262. doi: 10.1016/j.intimp.2022.109262. Epub 2022 Sep 24. Int Immunopharmacol. 2022. PMID: 36166972

10

The protective effect of rabeprazole on cisplatin-induced apoptosis and necroptosis of renal proximal tubular cells.

Chen SQ, Hu BF, Yang YR, He Y, Yue L, Guo D, Wu TN, Feng XW, Li Q, Zhang W, Wen JG. Chen SQ, et al. Among authors: he y. Biochem Biophys Res Commun. 2022 Jul 5;612:91-98. doi: 10.1016/j.bbrc.2022.04.107. Epub 2022 Apr 25. Biochem Biophys Res Commun. 2022. PMID: 35512462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,192 results

Search Page